Pharmafile Logo
Pharmafocus logo
Advanced Search

All new product marketing to be pre-vetted in UK

September 2, 2005
Medical Communications, Sales and Marketing

Advertising and marketing materials for all new products are to be vetted by the UK regulator for the accuracy of …

News

New NHS early warning system for long-term conditions

September 2, 2005

A new computer program will give NHS clinicians an early warning about patients at risk of being admitted to hospital.The …

News

Takeda’s dependence-free sleeping pill approved

September 2, 2005
Research and Development, Sales and Marketing

A new sleeping pill which patients cannot abuse or become dependent on has been approved in the US.Takeda's Rozerem (ramelteon) …

News

GP contract hailed as great success

September 2, 2005

GPs in England have been hailed as world leaders in chronic disease management by the government following the release of …

News

Mixed news for Lilly’s neuropathy drug

August 23, 2005

Lilly says it will file its new treatment for diabetic retinopathy with regulators by the end of the year – …

News

MHRA considers POM to P migraine drug switch

August 22, 2005
Sales and Marketing

News

Schering’s new low-dose contraceptive approved in Netherlands

August 19, 2005
Sales and Marketing

Yasminelle, a new low-dose oral contraceptive from Schering has received its first European marketing approval in the Netherlands. The country …

News

Recovery of healthcare PR highlights recruitment needs

August 18, 2005
Medical Communications

The mood of optimism in healthcare PR is set to continue following an average 15% growth among agencies' net income …

News

How to get inside your customer’s head

August 18, 2005
Sales and Marketing

Feature

Second batch of fake Lipitor discovered

August 18, 2005
Manufacturing and Production

The MHRA has discovered a second batch of counterfeit Lipitor in under a month, a worrying indication of a growing …

News

Pfizer acquires antibody optimisation company

August 17, 2005
Research and Development

Pfizer has purchased a company that develops technology to optimise antibodies to help it identify and develop new drugs with …

News

Acambis developing universal flu vaccine

August 17, 2005
Research and Development

Acambis has started developing a flu vaccine that could alter the market by offering permanent protection against influenza and guarding …

News

Global giant VNU acquires IMS Health for $7 billion

August 17, 2005
Sales and Marketing

Dutch media, consumer and marketing information group VNU has bought IMS Health for $7 billion, as it looks to expand …

News

FDA approves Diovan for cardiovascular indication

August 16, 2005
Sales and Marketing

Novartis' biggest selling drug Diovan has received US approval for a new indication, as it strives to bolster its position …

News

AstraZeneca’s Arimidex receives boost from study

August 11, 2005
Research and Development, Sales and Marketing

News

NICE rejects calls to fast-track cancer treatment

August 11, 2005
Sales and Marketing

News

Quintiles acquires site management organisation Profiad

August 11, 2005
Research and Development

Contract research organisation Quintiles has acquired Profiad, a market-leading site management organisation, giving it access to the Reading-based firm clinical …

News

Increasing the appeal of science

August 10, 2005
Research and Development

UK science students rate pharmaceutical companies as ideal employers, according to a new survey.GlaxoSmithKline, AstraZeneca and Pfizer are all rated …

Feature

New study says cancer risk from HRT only moderate

August 10, 2005
Research and Development

The risk of developing breast cancer while on hormone replacement therapy may be lower than thought, according to a new …

News

Equity fund snaps up biotech Xenova for

August 9, 2005
Research and Development, Sales and Marketing

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026